News Conference News VEITH 2019 Endovascular Office-Based Labs: Balancing Upsides Against Potential for Abuse L.A. McKeown November 28, 2019
News Conference News PCR London Valves 2019 Signal of Impaired Sapien XT Durability in Midterm Follow-up Michael O'Riordan November 20, 2019
News Conference News AHA 2019 AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials Shelley Wood November 11, 2019
News Conference News TCT 2019 Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences L.A. McKeown October 09, 2019
News Conference News TCT 2019 Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA Todd Neale October 04, 2019
News Conference News TCT 2019 TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3 Yael L. Maxwell September 29, 2019
News Conference News TCT 2019 Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR Todd Neale September 29, 2019
News Conference News TCT 2019 Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT Michael O'Riordan September 27, 2019
News Conference News TCT 2019 Learning Curve Exists for MitraClip, Volume-Outcomes Data Hint Todd Neale September 27, 2019
News Conference News TCT 2019 Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease Michael O'Riordan September 25, 2019
News Conference News TCT 2019 TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More Shelley Wood September 19, 2019
News Conference News ESC 2019 Nonphysician, Community Intervention Curbs CV Risk Factors: HOPE 4 Michael O'Riordan September 02, 2019
News Conference News ESC 2019 ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More Shelley Wood August 22, 2019
News Conference News TVT 2019 Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery Michael O'Riordan June 20, 2019
News Conference News TVT 2019 Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR Michael O'Riordan June 19, 2019
News Conference News TVT 2019 Faster and Larger Gains in Physical Function With TAVR Than With Surgery: SURTAVI Michael O'Riordan June 17, 2019
News Conference News TVT 2019 Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate Shelley Wood June 13, 2019
News Conference News SCAI 2019 TAVR Operators: Can One Do It All or Are Two Still Justified? Yael L. Maxwell June 04, 2019
News Conference News EuroPCR 2019 TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement Shelley Wood May 23, 2019
News Conference News EuroPCR 2019 Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats Michael O'Riordan May 22, 2019